The medical black technology system of the top student

In the early morning, William Kaelin made himself a cup of coffee and sat down in front of the computer.

Today is a Sunday, and there is nothing on his work schedule today. He was supposed to be driving his car and enjoying a wonderful holiday with his wife today.

But because of a special thing, William chose to return to his office.

Because, for the paper sent to those three reviewers, all three reviewers have completed the review work of the article.

In the past, it took a long time for reviewers to review manuscripts.

Because the reviewers are professors from some well-known universities or heads of some scientific research institutions.

They have their own work to do and need to wait until they have completed their work before they can spare time to review the manuscript.

But this time, perhaps it was because of William's urging. After all, the identity of the Nobel Prize winner was here, so they would give him more or less face.

Therefore, William quickly received the review opinions of Lu Liang’s article from three reviewers.

William turned on the computer and started his work today, and then opened the first email.

This is the most significant research result I have seen this year. It must be published. This article must be published as soon as possible. The sooner the better!

This is the opinion given by the first reviewer. The reviewer's evaluation of this paper is quite high.

This was exactly the same as William's idea. He also wanted to see this article published as soon as possible, so he urged three reviewers to expedite the review.

William then opened the email from the second reviewer.

The evaluation given by the second reviewer has some humor in it.

This will be a very influential paper. I am already considering whether I should also try to do some research on immunotherapy, laugh~

This guy is still as joking as ever, William thought to himself.

After seeing the evaluations given by the two reviewers, William couldn't help but smile.

All this was within his expectation. Everyone was a capable person, so they could naturally see the value of this article at a glance.

So it is natural to give such an evaluation.

Although William can now accept this article with the approval of two reviewers, William still wants to see the opinions of the third reviewer.

After all, this third reviewer can be said to be a heavyweight in the field of medicine.

In William's opinion, if nothing else happens, this third reviewer must have passed.

William subconsciously opened the third reviewer's review comments.

However, when William saw the third reviewer's opinion, he couldn't help but frown.

In my opinion, this paper is simply unacceptable. If such a paper can be published in the official journal of Science, it will make me very disappointed in Science.

The tone was harsh and the words were sharp, and the article was dismissed as worthless.

The third reviewer's opinion was completely beyond William's expectation.

How could such a valuable paper be dismissed as useless by a third reviewer?

This made William even wonder whether he had sent the wrong paper to the third reviewer.

But I didn’t send it wrong either!

William soon realized what the problem was.

He remembered that the third reviewer seemed to be the person in charge of a scientific research institution, and this scientific research institution seemed to have recently received sponsorship from several pharmaceutical companies.

Is it because the author of this article has conflicts with several well-known pharmaceutical companies?

It is not uncommon for William to use his influence to hinder the publication of articles. On the contrary, he has seen it many times.

Although I don’t know what conflicts there are between this scholar from China and which pharmaceutical companies.

But William scorned this behavior anyway. In his opinion, the third reviewer's behavior was hindering the development of science.

If it were another editor, he might still weigh the opinions of this third reviewer and hesitate to reject the article.

But William wouldn't care.

After all, who isn’t a heavyweight already?

Moreover, the two reviewers have already agreed, and now the decision of whether this article is accepted is in William's hands.

William simply skipped the third reviewer's opinion and made his own decision.

On behalf of Science, this article is officially accepted!

Pharmaceutical Research Institute.

Xu Shoulin said with a smile: Researcher Lu, thanks to your help this time, otherwise it would be really difficult for us to handle this matter.

With the launch of PD-1/TIGIT inhibitors, the Food and Drug Administration can punish sugalimab without any scruples.

Lu Liang waved his hand and said, It's not really a help. Even if you didn't tell me, I would still do it.

In fact, even if Xu Shoulin didn't say anything, Lu Liang's PD-1/TIGIT inhibitor would be on the market sooner or later.

Later, Lu Liang asked curiously: Then how did you handle this matter in the end?

Xu Shoulin said: We have temporarily removed sugemalimab from the shelves and asked Moco to resubmit an application so that sugemalimab can be put on the market again.

In addition, the market supervision personnel also punished the reporter who helped Moco Company in publicity. He was detained administratively for three months, his illegal gains were confiscated, and he was imposed an additional fine.

Now Tan Ting can be said to have lost his wife and lost his army. Not only was all his money confiscated, but he also lost his job. Most importantly, he still had to pay a fine.

Of course, the heaviest loss was caused by Moco.

The removal of sugalimab from the shelves was enough to bring Moco to its knees.

After all, Moko's subsequent application was approved and sugalimab was put back on the market, and the market had long been occupied by Lu Liang's drug.

Whether or not you can make more money is another matter.

However, this can be regarded as killing the chicken to scare the monkeys.

The severe punishment imposed on Moco this time made those pharmaceutical companies that were ready to imitate Moco suddenly become more honest.

Lu Liang nodded suddenly, and then he glanced at the number of source points in his system.

For now, drug sales have brought Lu Liang 4.3 source points.

At present, Lu Liang's source points have officially exceeded 7 source points, which is higher than before there were no analytical drugs.

Lu Liang is quite satisfied with this income from Yuandian.

After Xu Shoulin and others left, Lu Liang looked at Chen Shen and said, Director Chen, if nothing happens, I will go back first.

Chen Shen said: Don't worry, I have something else for you.

What is it? Lu Liang was a little confused.

Chen Shen stood up, took out a red certificate from the drawer and handed it to Lu Liang.